Alzheimer’s disease was discovered in 1906 by Dr. Alois Alzheimer when he examined the brain of a woman who appeared to have died from a mental illness that caused memories issues and erratic behavior. Upon examining this patient’s brain, he found abnormal lumps throughout the brain’s tissues and tangled bundles of fiber. These hallmarks of Alzheimer’s disease are now referred to as amyloid plaques and tau tangles, which are believed to inhibit the connections between neurons in the brain.
As the ability for nerves to connect in the brain worsens, memory problems and other cognitive deficits begin to present in those afflicted with disease, making it the 7th leading cause of death in the United States.
There is currently no cure of Alzheimer’s disease. However, Leqembi, a biologic, is a FDA approved disease modifying medication meant to treat the early stages of Alzheimer’s disease. However, there are other medications that are used to lessen symptoms, but ultimately will not slow the progression of the disease.
Some of these medications and therapies used to temporarily improve the symptoms and challenging behaviors of Alzherimer’s disease include acetylcholinesterase (AChE) inhibitors, memantine, antipsychotics, antidepressants, and cognitive stimulation therapy.
Since these medications and therapies are not a long-term solution that halts the progression of Alzheimer’s researchers are dedicating their resources into developing more biologic therapies that are disease modifying such as aduhelm and lecanemab which is currently seeking FDA approval.
At Pure Infusion Suites, we are experts at providing patients a comfortable, patient- obsessed infusion experience. Our clinical model guarantees we never go above a 3:1 patient to nurse ratio. Each Pure Infusion Suite is equipped with a 55 inch flatscreen TV, WiFi access, comfortable recliners, and food and beverages catered to our patient’s desires.
The patient experience at Pure Infusion Suites is unparalleled compared to the industry standards, especially when it comes to reducing costs for payers and patients.
On Average, care at an ambulatory infusion center costs 53% less than infusion services offered at hospitals. We further increase affordability by offering co-pay assistance and other financial aid programs to our patients to lessen their burdens.